维普期刊资源整合服务平台（V6.5）

63篇 您的检索式：作者名="SLACK JL"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Advances in the management of acute promyelocylic Leukemia and other hematologic malingnancies with arsenic trioxide显示文摘	SLACK JL WAXMAN S TRICOT G	2002	Oncologist2002，7，1：	1
2	Multicenter study of decitabine administered daily for 5 days every 4 weeks to adults with myelodysplastic syndromes:the alternative dosing for outpatient treatment (ADOPT)trial显示文摘	Steensma DP Baer MR Slack JL	2009	J Clin Oncol2009，27，23：	1
3	Multicenter study of decitabine administered daily for 5 days every 4 weeks to adults with myelodysplastic syndromes:the alternative dosing for outpatient treatment (ADOPT) trial显示文摘	Steensma DP Baer MR Slack JL	2009	J Clin Oncol2009，27，23：	1
4	Multicenter study of decitabine administered daily for 5 days every 4 weeks to adults with myelodysplastic syndromes: the alternative dosing for outpatient treatment (ADOPT) trial 显示文摘	Steensma DP Baer MR Slack JL	2009	J Clin Oncol2009，27，23：	1
5	Multicenter study of decitabine administered daily for 5 days every 4 weeks to adults with myelodysplastic syndromes; the alternative dosing for outpatient treatment (ADOPT) trial显示文摘	Steensma DP Baer MR Slack JL	2009	J Clin Oncol2009，27，23：	1
6	Multicenter study of deeitabine administered daily for 5 days every 4 weeks to adults with myelodysplastie syndromes:the al- ternative dosing for outpatient treatment(ADOPT)trial 显示文摘	Steensma DP Baer MR Slack JL	2009	Journal of Clinical Oneology Official Journal of the Ameriean Society of Clinical Oneology2009，27，23：	1
7	A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types显示文摘	McMahan CJ Slack JL Mosley B	1991	EMBO J1991，10，10：	1
8	Multicenter study of decitabine administered daily for 5 days every 4 weeks to adultswith myelodysplastie syndromes: the alternative dosing for outpatient treatment( ADOPT ) trial 显示文摘	SteensmaDP Baer MR Slack JL	2009	JClinOncol2009，27，23：	1
9	An essential role for ectodomain shedding in mammalian development显示文摘	Peschon JJ Slack JL Reddy P	1998	Science1998，282，：	1
10	Molecular analysis and clinical outcomeof adult APL patients with the type V PML-RARa isoform: results from Intergroup protocol0129显示文摘	Slack JL Willman CL Andersen JW	2000	Blood2000，95，：	1
11	Multieenter study of decit- abine administered daily for 5 days every 4 weeks to adults with myelodysplastic syndromes: the alternative dosing for outpatient treatment (ADOPT) trial显示文摘	Steensma DP Baer MR Slack JL	2009	J Clin Oncol2009，27，23：	1
12	Identification of two major sites in the type Ⅰ interleukin-1 receptor cytoplasmic region responsible for coupling to pro-inflammatory signaling pathways显示文摘	Slack JL Schooley K Bonnert TP	2000	J Biol Chem2000，275，7：	1
13	Muhicenter study of decitabine a&ninistered daily for 5 days every 4 weeks to adults with myelodysplastic syndromes: the alternative dosing for outpatient treatment (ADOPT) trial 显示文摘	Steensma DP Baer MR Slack JL	2009	J Clin Oncol2009，27，23：	1
14	Multicenter study of decitabine administered daily for 5 days every 4 weeks to adults with myelodysplastic syndromes:the alternative dosing for outpatient treatment(ADOPT)trial显示文摘	Steensma DP Baer MR Slack JL	2009	J Clin Oncol2009，27，：	1
15	Cloning of a putative ligand for the T1/ST2 receptor显示文摘	Gayle MA Slack JL Bonnert TP	1996	J Biol Chem1996，271，：	1
16	Regulation of expression of the type 1 collagen genes显示文摘	Slack JL Liska D Bomscin P	1993	Am J Med Genet1993，45，2：	1
17	Muhicenter study of decitabine administered daily for 5 days every 4 weeks to adults with myelodysplastie syndromes:the alternative dosing for outpatient treatment (ADOPT) trial显示文摘	Steensma DP Baer MR Slack JL	2009	J Clin Oncol2009，27，23：	1
18	Muhicenter study of decitabine administered daily for 5 days every 4 weeks to adults with myelodysplastic syndromes: the alternative dosing for outpatient treatment (ADOPT) trial显示文摘	Steensma DP Baer MR Slack JL	2009	J Clin Oneol2009，27，23：	1
19	Multi-center study of decitabine administered daily for 5 days every 4 weeks to adults with myelodysplastic syndromes:the alternative dosing for outpatient treatment (ADOPT) trial显示文摘	Steensma DP Baer MR Slack JL		0，，23：	1
20	Phase Ⅰ study of sequential vaccinations with fowlpox-CEA(6D)-TRICOM alone and sequentially with vaccinia-CEA(6D)-TRICOM,with and without granulocyte-macrophage colony-stimulating factor,in patients with carcinoembryonic antigen-expressing carcinomas显示文摘	Marshall JL Gulley JL Arlen PM Beetham PK Tsang KY Slack R	2005	J Clin Oncol2005，23，4：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示